Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6F7C

TUBULIN-Compound 12 complex

6F7C の概要
エントリーDOI10.2210/pdb6f7c/pdb
分子名称Tubulin alpha-1B chain, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER, ... (12 entities in total)
機能のキーワードcell cycle, tubulin fold, cytoskeleton, microtubule
由来する生物種Rattus norvegicus (Rat)
詳細
タンパク質・核酸の鎖数6
化学式量合計264870.68
構造登録者
Muehlethaler, T.,Prota, A.E.,Steinmetz, M.O. (登録日: 2017-12-08, 公開日: 2018-12-19, 最終更新日: 2024-01-17)
主引用文献Cury, N.M.,Muhlethaler, T.,Laranjeira, A.B.A.,Canevarolo, R.R.,Zenatti, P.P.,Lucena-Agell, D.,Barasoain, I.,Song, C.,Sun, D.,Dovat, S.,Yunes, R.A.,Prota, A.E.,Steinmetz, M.O.,Diaz, J.F.,Yunes, J.A.
Structural Basis of Colchicine-Site targeting Acylhydrazones active against Multidrug-Resistant Acute Lymphoblastic Leukemia.
Iscience, 21:95-109, 2019
Cited by
PubMed Abstract: Tubulin is one of the best validated anti-cancer targets, but most anti-tubulin agents have unfavorable therapeutic indexes. Here, we characterized the tubulin-binding activity, the mechanism of action, and the in vivo anti-leukemia efficacy of three 3,4,5-trimethoxy-N-acylhydrazones. We show that all compounds target the colchicine-binding site of tubulin and that none is a substrate of ABC transporters. The crystal structure of the tubulin-bound N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide (12) revealed steric hindrance on the T7 loop movement of β-tubulin, thereby rendering tubulin assembly incompetent. Using dose escalation and short-term repeated dose studies, we further report that this compound class is well tolerated to >100 mg/kg in mice. We finally observed that intraperitoneally administered compound 12 significantly prolonged the overall survival of mice transplanted with both sensitive and multidrug-resistant acute lymphoblastic leukemia (ALL) cells. Taken together, this work describes promising colchicine-site-targeting tubulin inhibitors featuring favorable therapeutic effects against ALL and multidrug-resistant cells.
PubMed: 31655259
DOI: 10.1016/j.isci.2019.10.003
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.002 Å)
構造検証レポート
Validation report summary of 6f7c
検証レポート(詳細版)ダウンロードをダウンロード

239803

件を2025-08-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon